Table 1.
Underlying conditions and Pneumocystis jirovecii positive qPCR (PjqPCR) results from the 324 patients included in the study.
| PjqPCR negative patients | PjqPCR positive patients | |
|---|---|---|
| Patient categories | n = 308 (%) | n = 16 (%) |
| Median age years (range) | 59 (15–97) | 58 (22–93) |
| Sex, male/female | 178/130 | 9/7 |
| HIV positive patients ( n = 18) | ||
| ≥ 200 CD4 T cells/μl ( n = 13) | 13 (0) | 0 |
| < 200 CD4 T cells/μl ( n = 6) | 5 (83) | 1 (17) |
| Hematological disorders ( n = 114) | ||
| Allogeneic hematologic stem cell transplantation ( n = 53) | 52 (98) | 1(2) |
| Chronic lymphoproliferative disorders ( n = 47) | 42 (89) | 5 (11) |
| Acute leukemia ( n = 20) | 20 (100) | 0 |
| Solid organ transplant recipients ( n = 15) | ||
| Kidney ( n = 16) | 14 (87) | 2 (13) |
| Lung ( n = 1) | 1 (100) | 0 |
| Patients with ≥30 mg steroid per day ≥30 days ( n = 16) | 15 (94) | 1 (6) |
| Patients with solid tumors ( n = 26) | 25 (96) | 1 (4) |
| None of the above conditions ( n = 126) | 121 (96) | 5 (4) |
| Total ( n = 324) | 308 (95.1) | 16 (4.9) |